{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-024625","form_type":"8-K","ticker":"WINT","cik":"0000946486","company_name":"WINDTREE THERAPEUTICS INC /DE/","filed_at":"2025-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.752101+00:00","generated_at":"2026-05-17T21:43:11.155857+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Director Leanne Kelly resigns from Windtree board; Andrew Kucharchuk appointed as replacement and Audit Committee chair","bullets":["Leanne Kelly resigned from Windtree Therapeutics board effective July 29, 2025; she had been Audit Committee chair.","Andrew Kucharchuk appointed to board effective August 3, 2025, also appointed chair of Audit Committee.","Kucharchuk is CFO of Cero Therapeutics Holdings and Chain Bridge I; previously CFO of Theralink Technologies.","No material arrangements, transactions, or compensatory grants disclosed in connection with Kucharchuk's appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-024625","json":"https://secwatch.observer/filing/0001437749-25-024625.json","markdown":"https://secwatch.observer/filing/0001437749-25-024625.md","text":"https://secwatch.observer/filing/0001437749-25-024625.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946486/000143774925024625/0001437749-25-024625-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946486/000143774925024625/wint20250804_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T21:43:11.155857+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}